KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other financing activities: 2010-2025

Historic Other financing activities for TherapeuticsMD (TXMD) over the last 1 years, with Mar 2025 value amounting to $23,000.

  • TherapeuticsMD's Other financing activities fell 79.28% to $23,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $298,000, marking a year-over-year increase of 7.97%. This contributed to the annual value of $1.3 million for FY2023, which is 61.74% down from last year.
  • Per TherapeuticsMD's latest filing, its Other financing activities stood at $23,000 for Q1 2025, which was down 79.28% from $111,000 recorded in Q1 2024.
  • Over the past 5 years, TherapeuticsMD's Other financing activities peaked at $5.0 million during Q1 2021, and registered a low of -$1.1 million during Q3 2023.
  • Over the past 3 years, TherapeuticsMD's median Other financing activities value was $67,000 (recorded in 2024), while the average stood at $234,167.
  • In the last 5 years, TherapeuticsMD's Other financing activities spiked by 300.00% in 2021 and then tumbled by 251.85% in 2023.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Other financing activities stood at $228,000 in 2021, then reached $2.6 million in 2022, then crashed by 50.98% to $1.3 million in 2023, then tumbled by 89.96% to $111,000 in 2024, then crashed by 79.28% to $23,000 in 2025.
  • Its last three reported values are $23,000 in Q1 2025, $111,000 for Q1 2024, and $1.3 million during Q4 2023.